Key4OI Recommendations for Lung Function Guidance in Osteogenesis Imperfecta Based on an Internationally Performed Comprehensive International Consortium for Health Outcomes Measurement ProcedureCHESTIF8.62023-05-014OA
Therapeutic beta-lactam dosages and broad-spectrum antibiotics are associated with reductions in microbial richness and diversity in persons with cystic fibrosisSCIENTIFIC REPORTSIF3.92023-01-213OAAI
Using metabolic potential within the airway microbiome as predictors of clinical state in persons with cystic fibrosisFRONTIERS IN MEDICINEIF32023-01-096OAAI
Impact of Antibiotics on the Lung Microbiome and Lung Function in Children With Cystic Fibrosis 1 Year After Hospitalization for an Initial Pulmonary ExacerbationOPEN FORUM INFECTIOUS DISEASESIF3.82022-09-123OAAI
Inflammation in children with cystic fibrosis: contribution of bacterial production of long-chain fatty acidsPEDIATRIC RESEARCHIF3.12021-03-0216OAAI
Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulationHELIYONIF3.62020-06-0110OAAI
Changes in microbiome diversity following beta-lactam antibiotic treatment are associated with therapeutic versus subtherapeutic antibiotic exposure in cystic fibrosisSCIENTIFIC REPORTSIF3.92019-02-2215OAAI
Benchmark Evaluation of True Single Molecular Sequencing to Determine Cystic Fibrosis Airway Microbiome DiversityFRONTIERS IN MICROBIOLOGYIF4.52018-05-257OAAI
Cardiopulmonary dysfunction in the Osteogenesis imperfecta mouse model Aga2 and human patients are caused by bone-independent mechanismsHUMAN MOLECULAR GENETICSIF3.22012-05-1561OAAI